Supply of coagulopathy products
Birmingham Women's and Children's NHS Foundation TrustcontractContracts Finder ↗Ref RQ303994complete
Estimated value
—
Awarded value
£200k
Awarded 23 Feb 2021
Suppliers
1
Lots
1
1 awarded
Published
15 Apr 2021
Deadline 16 Feb 2021
Description
Provision of SD plasma to be used in the treatment of coagulopathy
Scope
- Reference
- RQ303994
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2021 to 30 Mar 2022
- CPV classifications
- 33000000
Submission & procedure
- Submission deadline
- 16 Feb 2021, 5:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£200k
Award date
23 Feb 2021
Contract start
31 Mar 2021
Contract end
30 Mar 2022
Awarded to
Awarded suppliers· 1 supplier
Awarded 23 Feb 2021 · Contract period 31 Mar 2021 — 30 Mar 2022
Award value
£200k
Other contracts from Birmingham Women's and Children's NHS Foundation Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to OCTAPHARMA LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B) | contract | £72k | 12 Mar 2025 |
| NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin | contract | — | 20 Jan 2025 |
| Human Derived Blood Products | contract | — | 28 Aug 2024 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 | contract | — | 11 Jun 2024 |
| Octapharma Ltd - Octaplas LG | contract | £53k | 14 Jun 2023 |
| Octaplex Treatment | contract | £100k | 10 May 2023 |
| Blood product required for the treatment of TTP patients | contract | £98k | 03 Aug 2022 |
| NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B | contract | — | 04 Jul 2022 |
| Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | £64.3m | 23 Jul 2021 |
| NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | — | 22 Jul 2021 |